Short Interest in NKGen Biotech, Inc. (NASDAQ:NKGNW) Rises By 805.9%

NKGen Biotech, Inc. (NASDAQ:NKGNW) saw a significant growth in short interest in the month of January. As of January 15th, there was short interest totalling 15,400 shares, a growth of 805.9% from the December 31st total of 1,700 shares. Based on an average trading volume of 14,400 shares, the days-to-cover ratio is presently 1.1 days.

NKGen Biotech Stock Up 3.0 %

Shares of NKGNW traded up $0.00 during mid-day trading on Tuesday, reaching $0.11. 700 shares of the stock traded hands, compared to its average volume of 6,912. The firm has a fifty day moving average price of $0.08 and a 200 day moving average price of $0.08. NKGen Biotech has a 1 year low of $0.02 and a 1 year high of $0.29.

About NKGen Biotech

NKGen Biotech, Inc operates as a clinical-stage biotechnology company that focuses on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapies. It develops SNK01, an autologous NK cell therapy; and SNK02, an allogeneic NK cell therapy, which are in Phase 1 clinical trials.